🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06606717
Recruiting Not applicable

Effects of Resistance-band Training and Creatine and Whey Protein

NCT06606717 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2024-08-18
Last updated
2024-09-23

Condition(s) studied

Sarcopenia in Elderly

Investigational drug(s) / intervention(s)

Creatine Whey ProteinWhey Protein

Creatine Whey Protein: 3 grams creatine + 30 grams whey protein

Whey Protein: 30 grams Whey Protein

Study summary

The primary purpose of this research is to compare the effects of creatine monohydrate and/or whey protein supplementation during the first 10 weeks of a 20-week resistance-band training program on measures of body composition (whole-body lean tissue mass, total body water), arm and leg muscle thickness, upper- and lower-body muscle performance (i.e., strength, endurance) and functional ability (walking speed, balance). A secondary purpose of this research is to examine the effects of supplementation cessation (i.e., no creatine and/or whey protein supplementation) during the final 10 weeks of the 20-week resistance-band training program on these measures.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Untrained (defined as those performing ≤ 1 resistance training session per week for ≥ 6 weeks prior to the start of the study) Exclusion Criteria: * Taking creatine monohydrate within 30 days prior to the start of the study * Currently ingesting whey protein * Have pre-existing allergies to latex, fruit, dairy, nuts, seafood and mustard

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Regina Regina Saskatchewan Recruiting

More University of Regina trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06606717 on ClinicalTrials.gov ↗ ← All trials in Canada